Hammerson’s New CEO Has £1M in Company Shares — Will He Buy More?

The stage is set for a major handoff at Hammerson. Chief Executive Rita-Rose Gagné has announced she will retire in 2026, stepping down after five years at the helm. She framed the move as a confident exit, stating it's the "right time" to pass the baton because the company is in great shape with strong momentum. Her tenure saw a clear turnaround, transforming the business into the UK's largest listed pure-play owner of prime retail and leisure destinations. The Board, led by Chair Robert Noel, praised her "outstanding leadership" and confirmed a formal search for her successor is underway.

The new leader is already in place. Rob Wilkinson, a 30-year real estate veteran from AEW Europe, will join as CEO designate on December 15 and officially take the reins from 1 January 2026. The appointment followed a rigorous search, with the Chair highlighting Wilkinson's proven track record in delivering shareholder value. He inherits a company that has completed its portfolio restructuring and is now in a "new phase of growth," according to his own statement.

But for the smart money watching, the transition isn't just about the new CEO's credentials. It's about the actions of those already inside the gates. The key insider transaction to note is the sale by Harry Badham, a key managerial figure, of shares upon the vesting of a Restricted Share Award. The company disclosed that a portion of these shares was sold to cover associated tax liabilities. This is a routine event, but it's the first concrete signal from the current guard as the baton is passed. The thesis for this analysis is clear: as the turnaround story enters its next phase, the smart money is watching whether the outgoing CEO's final actions and the new CEO's skin in the game signal genuine confidence or quiet concern. The filings will tell us what the insiders are really thinking.

Decoding the Insider Moves: Skin in the Game or Exit Strategy?

The first concrete insider action as the transition unfolds is a routine, neutral transaction. Key managerial figure Harry Badham sold a portion of his vested shares to cover tax liabilities, a standard move that the company disclosed complies with market rules. This isn't a signal of confidence or concern; it's just the mechanics of a restricted share award coming due. The real watchpoint is whether the new CEO and other executives are buying shares to demonstrate their skin in the game.

Rob Wilkinson, the incoming leader, has a significant stake in the company's future. He will be eligible for Hammerson's annual incentive plan and restricted share scheme, and he has already been granted buyout awards worth £1.017 million in shares. The critical question for the smart money is whether he and other executives are using their own capital to buy more shares in the open market. Their purchases would align their fortunes directly with the new growth narrative. Without such buying, the alignment of interest remains theoretical, resting solely on the promise of a new CEO's track record.

Zooming out, the broader market saw a wave of institutional buying recently. On March 13, Manufacturers Life Reinsurance Ltd made a major open market purchase of nearly 1 million shares in a different company. While this isn't a Hammerson trade, it shows a pattern of institutional accumulation in the market. For Hammerson, the smart money will be looking for similar whale wallets to move in, not just the routine tax sales of the outgoing guard. The new CEO's first moves will tell us if he's ready to put his own money where his mouth is.

Financial Health vs. Valuation: Is the Turnaround Priced In?

The operational story is clear: Hammerson has delivered a full-scale turnaround. The company posted its first full-year positive IFRS profit since 2017, raised its dividend by 6%, and guided for continued expansion. Management expects ~20% NRI growth and EPRA earnings of ~£120m in 2026. This isn't just a one-quarter pop; it's a multi-year acceleration with occupancy at 96%, footfall rising, and record new lettings. The financial health is solid, with a strong balance sheet and a clear path forward.

Yet the valuation tells a different story. Despite this momentum, the stock trades at a 27% discount to its net asset value (NAV) and offers a 5.8% dividend yield. That gap is the smart money's opportunity. A 27% discount suggests the market is either skeptical of the sustainability of the growth or hasn't fully priced in the portfolio's revaluation. The yield, meanwhile, is a tangible return for patient investors.

For institutional accumulation to truly begin, the smart money needs to see the valuation gap close. The current setup provides a buffer-buying at a discount to NAV with a high yield means downside is limited even if growth stumbles. But the real signal will be if the new CEO's skin in the game and the company's own capital allocation start to reflect a belief that the turnaround is fully priced. Right now, the numbers show a company in great shape trading at a bargain. The question is whether the whales see it that way.

Catalysts and Risks: What Smart Money Will Watch

For institutional investors, the bullish thesis now hinges on a few clear catalysts and a looming risk. The smart money will be watching for concrete signals that the board's confidence in the new CEO translates into skin in the game and that the operational momentum holds.

The first major watchpoint is the formal announcement of Rob Wilkinson's compensation package. While his base salary and buyout awards are disclosed, the critical element is the size and structure of his annual incentive plan and any restricted share awards granted under the new regime. This will signal how much the board is willing to tie his personal fortune to the company's performance. A generous, long-vested equity package would demonstrate strong alignment. Without it, the new CEO's promises remain just that.

Next, the market will scrutinize the execution of the 2026 guidance. Management expects ~20% NRI growth and EPRA earnings of about £120m. The real test will be whether the company hits these targets, particularly the NRI growth, while maintaining its strong balance sheet (LTV ~39%). Consistent delivery on these numbers would validate the turnaround narrative and likely attract more institutional accumulation. Any deviation, especially on the growth metric, could trigger a reassessment.

The key risk, however, is the leadership transition itself. The smart money will exit if insider selling accelerates post-transition. The recent sale by Harry Badham to cover taxes was routine. But if other executives, or even the new CEO, begin selling shares in the open market soon after taking the reins, it would be a powerful signal of misalignment. The thesis is that the new guard is ready to lead, but the filings will show if they are truly putting their own money on the line. For now, the setup offers a discount to NAV and a high yield, but the whales will wait for the first moves from the new CEO's wallet.